This ticker has not been starred yet EBS Emergent Biosolutions Inc.
Pharmaceutical Preparations
Book value per $ invested $ 1.08
Leverage 60.13%
Market Cap $ 538.7m
PE 7.00
Dividend Yield 0.00%
Profit $ 76.9m
Margin 9.08%

Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHT). The company is headquartered in Gaithersburg, Maryland.

Subscribe Now For Access - Only $1.99 Per Month